ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
J

Lecture Summary - ASCO 2022 on ARTISTRY-6 Trial: Nemvaleukin Alfa Monotherapy in Advanced Mucosal and Cutaneous Melanoma

By ASCO 2022 Conference Coverage FEATURING Jeffrey Weber
By ASCO 2022 Conference Coverage FEATURING Jeffrey Weber
26 views
June 27, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse
Skin
10:27

ASCO 2022 Updates on DREAMseq (Doublet, Randomized Evaluation in Adv…

ASCO 2022 Conference Coverage

M. Atkins

219 views
01:37

Lecture Summary - ASCO 2022 on Anti-PD-1 Antibody: Plus One or Plus …

ASCO 2022 Conference Coverage

A. Daud

20 views
18:11

ASCO 2022 on Anti-PD-1 Antibody: Plus One or Plus Two

ASCO 2022 Conference Coverage

A. Daud

271 views
14:22

ASCO 2022 Nivo + Rela vs. Nivo in Previously Untreated Metastatic/Un…

ASCO 2022 Conference Coverage

E. Lipson

340 views
02:01

Lecture Summary - ASCO 2022 Meta-Analysis of Randomized Phase II-III…

ASCO 2022 Conference Coverage

P. Francesco Ferrucci

16 views
09:28

ASCO 2022 Meta-Analysis of Randomized Phase II-III Trials Evaluating…

ASCO 2022 Conference Coverage

P. Francesco Ferrucci

114 views
05:48

ASCO 2022 on the Role of Metastasectomy in Advanced BRAF+ Melanoma D…

ASCO 2022 Conference Coverage

K. Orlova

304 views
04:30

ASCO 2022 on ARTISTRY-6 Trial: Nemvaleukin Alfa Monotherapy in Advan…

ASCO 2022 Conference Coverage

J. Weber

123 views
50

Lecture Summary - ASCO 2022 on ARTISTRY-6 Trial: Nemvaleukin Alfa Mo…

ASCO 2022 Conference Coverage

J. Weber

26 views
27

Lecture Summary - ASCO 2022 on Long-Term Toxicities With Immune Chec…

ASCO 2022 Conference Coverage

J. Tong

321 views
11:46

ASCO 2022 on Long-Term Toxicities With Immune Checkpoint Inhibitor i…

ASCO 2022 Conference Coverage

J. Tong

515 views
05:28

ASCO 2022 Primary Ipi/Nivo Followed by Adjuvant Nivo in Pts With Loc…

ASCO 2022 Conference Coverage

E. Cocorocchio

210 views
06:03

ASCO 2022 on Survival Update of Neoadjuvant Ipi + Nivo in Macroscopi…

ASCO 2022 Conference Coverage

J. Versluis

44 views
07:54

ASCO 2022 Phase II SECOMBIT Study on Optimal Treatment Sequencing in…

ASCO 2022 Conference Coverage

P. Ascierto

113 views
01:23

Lecture Summary - ASCO 2022 on Thromboembolism and Association With …

ASCO 2022 Conference Coverage

T. Sussman

18 views
08:48

ASCO 2022 on Thromboembolism and Association With Survival in Pts Wi…

ASCO 2022 Conference Coverage

T. Sussman

115 views
16:53

ASCO 2022: Real-World Evaluation of the Association Between Baseline…

ASCO 2022 Conference Coverage

Z. Eroglu

134 views
09:33

ASCO 2022 on ImmunoCobiVem Study Interim Analysis: The Efficacy & Sa…

ASCO 2022 Conference Coverage

E. Livingstone

125 views
55

Lecture Summary - ASCO 2022 Nivolumab + Relatlimab vs. Nivo in 1L Me…

ASCO 2022 Conference Coverage

P. Rutkowski

22 views
05:06

ASCO 2022 on RELATIVITY-047 Trial: Nivolumab + Relatlimab vs. Nivo i…

ASCO 2022 Conference Coverage

P. Rutkowski

1.1K views
45

Lecture Summary - ASCO 2022 Long-Term Survival in Advanced Melanoma …

ASCO 2022 Conference Coverage

P. Rutkowski

17 views
04:49

ASCO 2022 Long-Term Survival in Advanced Melanoma for Pts Treated Wi…

ASCO 2022 Conference Coverage

P. Rutkowski

136 views
14:06

ASCO 2022 Analysis of the Effect of Systemic Corticosteroids on Surv…

ASCO 2022 Conference Coverage

A. Ikeguchi

62 views